Sugammadex
From WikiAnesthesia
Revision as of 05:02, 18 February 2021 by Chris Rishel (talk | contribs) (Created page with "{{Infobox drug reference | trade_names =Bridion | drug_class = | drug_class_color =neuromuscular_blocker_reversal | uses =Reversal of neuromuscular blockade from Rocuroni...")
Sugammadex
| Trade names |
Bridion |
|---|---|
 | |
| Clinical data | |
| Uses |
Reversal of neuromuscular blockade from rocuronium and vecuronium |
| Contraindications |
Renal impairment |
| Routes of administration |
Intravenous |
| Dosage |
Based upon response to train-of-four stimulation:
|
| Pharmacodynamics | |
| Mechanism of action |
Encapsulation of rocuronium or vecuronium |
| Adverse effects |
Bradycardia, may interfere with hormonal contraceptives |
| Pharmacokinetics | |
| Physical and chemical data | |
| Formula |
C72H112O48S8 |
| Molar mass |
2002.12 g/mol |
| Article quality | |
| Editor rating | |
| User likes | 0 |
Sugammadex is used to reverse neuromuscular blockade from rocuronium and vecuronium.
Uses
Contraindications
Absolute contraindications
Precautions
Pharmacology
Pharmacodynamics
Mechanism of action
Adverse effects
Pharmacokinetics
Chemistry and formulation
History
References
Top contributors: Chris Rishel and Tymoteusz Kajstura